Medtech
Navigate Regulation, Demonstrate Safety, Accelerate Access
The medical device and in vitro diagnostic industry is navigating one of the most significant regulatory transitions in its history. The EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) have fundamentally raised the bar for market access, clinical evidence requirements, and post-market obligations — creating both compliance pressure and strategic opportunity for companies that plan ahead.
PLG’s MedTech team combines regulatory expertise with deep knowledge of MDR and IVDR frameworks to support device and diagnostic companies through every phase of the product lifecycle. From initial regulatory strategy and technical documentation through quality management system design, clinical evaluation, and post-market clinical follow-up, our specialists work alongside your teams to ensure your products meet European and international requirements efficiently and sustainably.
Success in today’s MedTech environment demands more than regulatory compliance — it requires proactive evidence generation, robust quality systems, and the ability to turn post-market data into actionable insights that support continuous improvement and regulatory dialogue. Our goal is to help you maintain market access, protect your product’s position, and build the foundation for long-term commercial success.
Our 5 MedTech services — Medical Device and MedTech Services, MDR & IVDR Compliance, Quality Management Systems, Post-Market Surveillance, and Clinical Evaluation & PMCF — are designed to work as an integrated offer or to complement your existing capabilities where specialist support is needed most.
Comprehensive regulatory and development support across the product lifecycle, from concept through commercialization and beyond.
Expert guidance navigating MDR and IVDR requirements, ensuring compliant transitions and sustained market access.
ISO 13485-compliant QMS design, implementation, and optimization tailored to your organizational needs and regulatory requirements.
Structured PMS systems that meet regulatory obligations while generating actionable insights for product improvement and risk management.
Rigorous clinical evaluations and post-market clinical follow-up strategies that demonstrate ongoing safety and performance.